Recruiting Myeloproliferative Neoplasms Studies in Charlotte
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
The purpose of this study is to evaluate the efficacy and safety of bomedemstat compared with hydroxyurea in cytoreductive therapy naïve essential thrombocythemia (ET) participants for whom cytoreduct...
Study of Canakinumab in Patients With Myelofibrosis
This is an open label, multicenter, phase 2 trial of Canakinumab in patients with primary myelofibrosis (PMF), post essential thrombocythemia/polycythemia vera related MF (Post ET/PV MF). Eligible pat...
About Myeloproliferative Neoplasms Clinical Trials in Charlotte
Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.
There are currently 2 myeloproliferative neoplasms clinical trials recruiting participants in Charlotte, NC. These studies are seeking a combined 314 participants. Research is being sponsored by Merck Sharp & Dohme LLC, John Mascarenhas. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myeloproliferative Neoplasms Clinical Trials in Charlotte — FAQ
Are there myeloproliferative neoplasms clinical trials in Charlotte?
Yes, there are 2 myeloproliferative neoplasms clinical trials currently recruiting in Charlotte, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Charlotte?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Charlotte research site will contact you about next steps.
Are clinical trials in Charlotte free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Charlotte studies also compensate for your time and travel.
What myeloproliferative neoplasms treatments are being tested?
The 2 active trials in Charlotte are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.
Data updated March 2, 2026 from ClinicalTrials.gov